Investor Relations

• Q1 2024 Group sales at $7.4 billion, -20% (-18% at CER) versus prior year
• Q1 2024 EBITDA at $1.2 billion, -34% (-26% at CER) versus prior year  
• Results in line with expectations for first quarter 2024 amid continued destocking by distributors and retailers
• Group announces new sustainability priorities, fully embedding sustainability in its business strategy, while adding a new level of transparency

Q4 saw continued demand for new, innovative crop protection products; double-digit growth in China

• FY 2023 Group sales at $32.2 billion, -4% versus prior year
  • Q4 Group sales grew to $7.9 billion, +5% versus prior year
• FY 2023 EBITDA at $4.6 billion, -18% versus prior year
  • Q4 EBITDA at $1.0 billion, +15% versus prior year
• Syngenta Group China achieved strong 11% year-over-year sales growth, reaching $9.6 billion in FY 2023
  • FY 2023 MAP and digital sales in China grew 26% versus prior year
• Continued demand in an overall challenging Crop Protection market environment for new innovative technologies
  • Insect-control products containing PLINAZOLIN^® technology achieving particularly strong sales across Brazil and Asia Pacific